tirzepatide for ckd (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide and Chronic Kidney Disease:

Current law prohibits Medicare from covering obesity drugs and gives states flexibility to cover weight loss drugs under Medicaid Limitations on coverage for obesity drugs in Medicare and Medicaid mean that millions of people who have obesity and might benefit from taking GLP-1s may be unable to access them unless they are able to pay the full cash price out of their own pockets, which would likely be prohibitive for people with Medicaid who must have low incomes to qualify for the program, as well as for many people on Medicare with low and modest incomes

Weight Loss Injections Weight Loss and Wellness Originally developed for managing type 2 diabetes, GLP-1 injections can also support sustainable weight loss in patients

People should take the Wegovy pill in the morning after fasting overnight and with no more than 4 ounces of water

What will I learn